)
Visual
test
ODI Pharma
ODI Pharma (ODI) investor relations material
ODI Pharma Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary26 Feb, 2026
Executive summary
Achieved strong revenue growth in Q2 2025/2026, with net sales of SEK 10.9 million, up from SEK 0 in the prior year’s quarter and up 84% sequentially from Q1 2025/2026.
Returned to profitability in Q2, with profit after financial items of SEK 1.3 million versus a loss of SEK -2.6 million in the prior year.
Six-month net sales reached SEK 16.9 million, with profit after financial items of SEK 1.26 million, both significantly improved year-over-year.
Operational stability, improved logistics, and increased order volumes contributed to financial strength and market share gains in Eastern Europe.
Financial highlights
Q2 net sales: SEK 10,932,119 (0 prior year); six months: SEK 16,900,262 (-4,965 prior year).
Q2 profit after financial items: SEK 1,298,597 (-2,562,520 prior year); six months: SEK 1,255,378 (-3,953,290 prior year).
Earnings per share for six months: SEK 0.07 (-0.25 prior year).
Group solidity at 19% as of December 31, 2025, up from 7% a year earlier.
Cash flow from operations in Q2: SEK 1,984,285 (-1,560,867 prior year).
Outlook and guidance
Additional deliveries scheduled for Q3, with continued commercial momentum expected.
Expansion opportunities being assessed in regulated European medical cannabis markets.
Growth in demand for medical cannabis products anticipated, especially in Poland and Eastern Europe.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ODI Pharma
- Q1 net sales soared and losses narrowed, reflecting improved stability and growth in Poland.ODI
Q1 202627 Nov 2025 - Revenue fell and losses deepened, but financial position was strengthened for future growth.ODIQ4 202528 Aug 2025
- Q1 loss and revenue decline offset by optimism from Poland's increased cannabis import quota.ODIQ1 202513 Jun 2025
- ODI Pharma posted robust revenue growth and profitability, focusing on European medical cannabis.ODIQ4 202413 Jun 2025
- Sales fell and losses widened, but import issues resolved and profitability expected to return.ODIQ3 20256 Jun 2025
- ODI Pharma faces losses but secures funding and grows its Polish medical cannabis market share.ODIQ2 20256 Jun 2025
Next ODI Pharma earnings date
Q3 202628 May, 2026
ODI Pharma
Next ODI Pharma earnings date
Q3 202628 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage